Drug news
Mallinckrodt to co market Sumavel Dose Pro for Migraine in US
Zogenix Inc. have appointed Mallinckrodt to co market Sumavel Dose Pro in the US. The 95-person Zogenix sales force in the US targeting neurologists, headache specialists and other physicians will be joined by a team of Mallinckrodt sales representatives who market pain drugs to primary care doctors.